Dolutegravir Sodium PurCert Secondary Reference Standard (Traceable to EP CRS) [Includes all characterization data]

PurCert

Synonym: sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate

Linear Formula: C₂₀H₁₈F₂N₃NaO₅

Molecular Weight: 441.37 g/mol

CAS Number: 1051375-19-9

Properties

Assay Purity	>=99%
M pt.	>300 °C
Form	Solid

Safety Information

Hazard Statement(s)	H302-H315-H319-H335
Precautionary Statement	P261-P305+P351+P338
GHS Pictogram
Signal word	Warning
Storage Temp.	2-8 °C

Description

Application

Dolutegravir Sodium is used as a component of combination antiretroviral therapy for the treatment of Human Immunodeficiency Virus Infection in adults and children to help achieve and maintain viral suppression

Purpose

The purpose of Dolutegravir Sodium is to inhibit the HIV integrase enzyme thereby preventing the virus from integrating its genetic material into human cells and reducing viral replication.

General Description

Dolutegravir Sodium is the sodium salt form of dolutegravir an antiretroviral drug that belongs to the integrase strand transfer inhibitor (INSTI) class and is used in the treatment of HIV infection.

Documents


SDS
COA
Specification
Bulk quote order form